Oral Abstract NHL 122: Durability of Response in Patients With Refractory Large B Cell Lymphoma Treated With Axicabtagene Ciloleucel in the Pivotal Phase 2 Study, ZUMA-1

18 views
October 25, 2018
0 Comments
Login to view comments. Click here to Login